Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cannabidivarin

EU orphan designation number: EU/3/18/1977   
Active ingredient: Cannabidivarin
Indication: Treatment of fragile X syndrome
Sponsor: GW Pharma (International) B.V
Databankweg 26, Amersfoort, Utrecht, 3821 AL, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/02/2018 Orphan designation EMA/OD/215/17 (2018)1244 of 22/02/2018
12/04/2019 Transfer of orphan designation EMA/OD/0000004768 (2019)2929 of 10/04/2019